KYTXKyverna Therapeutics, Inc.

Healthcare
$5.38-19% 1Y
Latest close: a new 52-week lowOct 23, 2026what changed →

The financials

Kyverna Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 11, 2026, the same week as a year ago.

Kyverna Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$40M−$44Mn/a
Net income−$38M−$42Mn/a
Diluted EPS−$0.63−$0.97n/a

Biotechnology

The closest names by size in the same industry

Compare peers
OBIO+1.7%
Orchestra BioMed Holdings, Inc.
ENTA+0.26%
Enanta Pharmaceuticals
AVIR0.00%
Atea Pharmaceuticals, Inc.
ZURA-4.5%
Zura Bio Ltd
CAPR-3.5%
Capricor Therapeutics, Inc.
RLMD-1.2%
Relmada Therapeutics